Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gale M England"'
Autor:
Rachel Podrazik Baer, Kelly Danielle Foster, Lauren Allison Wiebe, Ami N. Shah, Mary Pasquinelli, Julia R. Trosman, Valerie Nelson, Michelle Stamp, Jean J Bao, Lawrence Eric Feldman, Claudia B. Perez, Neil Dalal, Rosa Berardi, Christine B. Weldon, Mary Ellen Hand, Gale M England, Al B. Benson, Sheetal Mehta Kircher, William J. Gradishar, Betty Roggenkamp
Publikováno v:
Journal of Clinical Oncology. 38:e24051-e24051
e24051 Background: CSOC conducts quality improvements (QI) for cancer patients that facilitate delivery of appropriate health maintenance and supportive cancer care at diagnosis and during treatment. CSOC is implementing a care planning QI starting a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e140ec8be6acebfd31a4104655289fbc
https://doi.org/10.1200/jco.2020.38.15_suppl.e24051
https://doi.org/10.1200/jco.2020.38.15_suppl.e24051
Autor:
V. Craig Jordan, Kathy Yao, Gale M. England, Hiroyuki Takei, Ruth O'Regan, Henry D. Muenzner, Jennifer I. Macgregor
Publikováno v:
Breast Cancer. 5:211-217
Laboratory models for breast and endometrial cancer have had an enormous impact on the clinical development of antiestrogens. Results from the DMBA-induced rat mammary cancer model has provided the scientific principles required to evaluate long-term
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7413d2d4817da643a8cdacb9e8a85bfe
https://doi.org/10.1007/bf02966699
https://doi.org/10.1007/bf02966699
Publikováno v:
The Journal of Steroid Biochemistry and Molecular Biology. 65:181-189
The new antiestrogen toremifene (TOR) is currently on the market for the treatment of advanced breast cancer in postmenopausal women. TOR is known to exhibit a similar efficacy profile as tamoxifen (TAM) in the treatment of advanced breast cancer and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::858221d9c7c7958f77e3d6e19355be3e
https://doi.org/10.1016/s0960-0760(98)00011-9
https://doi.org/10.1016/s0960-0760(98)00011-9
Autor:
Kathy Yao, Henry D. Muenzner, V. Craig Jordan, Gale M. England, Anait S. Levenson, Ruth O'Regan, Hiroyuki Takei
Publikováno v:
Hormone Therapy in Breast and Prostate Cancer ISBN: 9781607614715
Tamoxifen (Nolvadex®) (Fig. 1), a nonsteroidal antiestrogen, is the endocrine treatment of choice for all stages of breast cancer. The drug has ten million women years of clinical experience and is described by the World Health Organization (WHO) as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b90c8de1a81405eade87026e7398796d
https://doi.org/10.1007/978-1-59259-152-7_3
https://doi.org/10.1007/978-1-59259-152-7_3
Autor:
Virgil Craig Jordan, Vasilios J. Assikis, Zehan Chen, Malcolm M. Bilimoria, Henry D. Muenzner, Gale M. England
Publikováno v:
International journal of oncology. 12(5)
It is clear that growth of the MCF-7 breast cancer cell line is stimulated by estrogen and when estrogen is removed, growth slows. We have observed a tumor derived from MCF-7 cells that grows in athymic mice in the absence of estrogen stimulation. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e1261e7700929adae43f4856699f46c
https://pubmed.ncbi.nlm.nih.gov/9538117
https://pubmed.ncbi.nlm.nih.gov/9538117
Autor:
Gale M England
Publikováno v:
Journal of the American College of Surgeons. 185:308
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::792f875e9e229e3711fe43725c5e63db
https://doi.org/10.1016/s1072-7515(00)00821-8
https://doi.org/10.1016/s1072-7515(00)00821-8